Clinical Trial Update: Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Trauma

View source ↗

Summary

A prospective registry sponsored by Artoss Inc. to evaluate outcomes of NanoBone bone graft in acute bone fractures; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Fractures

Drugs mentioned

• NanoBone Bone Graft (bone graft material)

Snippet

Sponsor: Artoss Inc. | Conditions: Fractures, Bone | Status: RECRUITING